FDA notifications. FDA grants approval for generic didanosine for oral solution.
D000284:Administration, Oral; D016049:Didanosine / Q000008:administration & dosage / Q000627:therapeutic use; D017277:Drug Approval / Q000331:legislation & jurisprudence*; D016568:Drugs, Generic; D018894:Reverse Transcriptase Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use; D012996:Solutions; D014481:United States; D014486:United States Food and Drug Administration
D016568:Drugs, Generic; D018894:Reverse Transcriptase Inhibitors; D012996:Solutions; D016049:Didanosine